TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) › Gross ProfitTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2007: $4.88B2008: $5.97B2009: $7.37B2010: $9.06B2011: $9.52B2012: $10.65B2013: $10.71B2016: $11.65B2017: $10.62B2018: $8.30B2019: $7.54B2020: $7.73B2021: $7.59B2022: $6.97B2023: $7.64B2024: $8.06B2025: $8.94B$8.94B2007Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$8.94B+10.8%2024$8.06B+5.5%2023$7.64B+9.6%2022$6.97B-8.2%2021$7.59B-1.7%2020$7.73B+2.5%2019$7.54B-9.1%2018$8.30B-21.8%2017$10.62B-8.9%2016$11.65B—2013$10.71B+0.5%2012$10.65B+11.9%2011$9.52B+5.0%2010$9.06B+23.0%2009$7.37B+23.4%2008$5.97B+22.4%2007$4.88B—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share